Press Release Aug 09 2024
Filed with NSE · · 7 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has released its unaudited consolidated financial results for the first quarter of the fiscal year, reporting significant growth in revenue and profit compared to the previous year. The company achieved a notable increase in revenue from operations and net profit, reflecting strong performance across its business segments.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
In the deck
Earlier from Zydus Lifesciences
- Press Release Jul 31 2024
- Press Release Jul 23 2024
- Press Release Jul 22 2024
- Press Release Jul 19 2024
- Press Release Jul 17 2024
Later from Zydus Lifesciences
- Press Release Aug 23 2024
- Press Release Aug 27 2024
- Press Release Aug 30 2024
- Zydus receives final approval from USFDA for Scopolamine Transdermal System 1 mg/3 days
- Press Release Sep 10 2024
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences